Mirae Asset Global ETFs Holdings
ANRO icon

Mirae Asset Global ETFs Holdings’s Alto Neuroscience ANRO Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,757
Closed -$27.6K – 3276
2025
Q1 		$27.6K Buy
12,757
+546
+4% +$1.95K ﹤0.01% 2945
2024
Q4 		$51.7K Buy
12,211
+532
+5% +$3.32K ﹤0.01% 2896
2024
Q3 		$134K Buy
+11,679
New +$143K ﹤0.01% 2563

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ANRO Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Alto Neuroscience (ANRO) in Q2 2025, closing a stake of 12,757 shares — an estimated $27.6K sold.

Mirae Asset Global ETFs Holdings first reported a position in ANRO in Q3 2024 and held it in 3 quarters. The position peaked at $134K in Q3 2024. 80 funds tracked by Wall St. Rank hold ANRO as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Alto Neuroscience position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 12,757 Alto Neuroscience shares in Q2 2025, an estimated $27.6K.
  • Mirae Asset Global ETFs Holdings first reported a position in Alto Neuroscience in Q3 2024 and held it in 3 quarters.
  • Mirae Asset Global ETFs Holdings's Alto Neuroscience position peaked at $134K in Q3 2024.
  • 80 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.